CellXplore Overview

  • Founded
  • 2007


  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

CellXplore General Information


Operator of a technology platform intended to facilitate the discovery of biomarkers. The company's technology platform is into identifying biomarkers for non-invasive diagnosis of breast cancer using biochemical analysis of blood samples, enabling clients to classify disease-specific biomarkers and target for drug discovery in human diseases and also apply it in the field of animal science.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 120 Albany Street, Tower II
  • Suite 850
  • New Brunswick, NJ 08901
  • United States
+1 (732) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellXplore Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2018 00000 Completed Out of Business
1. Early Stage VC 01-Oct-2007 00000 00000 Completed Startup
To view CellXplore’s complete valuation and funding history, request access »